- Home
- IAF vs ALEC Comparison
IAF vs ALEC Comparison
Compare IAF & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAF
- ALEC
- Stock Information
- Founded
- IAF 1985
- ALEC 2013
- Country
- IAF United States
- ALEC United States
- Employees
- IAF N/A
- ALEC N/A
- Industry
- IAF Finance/Investors Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IAF Finance
- ALEC Health Care
- Exchange
- IAF Nasdaq
- ALEC Nasdaq
- Market Cap
- IAF 103.9M
- ALEC 124.0M
- IPO Year
- IAF N/A
- ALEC 2019
- Fundamental
- Price
- IAF $4.45
- ALEC $1.52
- Analyst Decision
- IAF
- ALEC Buy
- Analyst Count
- IAF 0
- ALEC 7
- Target Price
- IAF N/A
- ALEC $4.70
- AVG Volume (30 Days)
- IAF 90.4K
- ALEC 571.9K
- Earning Date
- IAF 01-01-0001
- ALEC 08-06-2025
- Dividend Yield
- IAF 11.44%
- ALEC N/A
- EPS Growth
- IAF N/A
- ALEC N/A
- EPS
- IAF N/A
- ALEC N/A
- Revenue
- IAF N/A
- ALEC $88,339,000.00
- Revenue This Year
- IAF N/A
- ALEC N/A
- Revenue Next Year
- IAF N/A
- ALEC $319.82
- P/E Ratio
- IAF N/A
- ALEC N/A
- Revenue Growth
- IAF N/A
- ALEC N/A
- 52 Week Low
- IAF $3.60
- ALEC $0.87
- 52 Week High
- IAF $4.59
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- IAF 56.39
- ALEC 51.94
- Support Level
- IAF $4.35
- ALEC $1.36
- Resistance Level
- IAF $4.48
- ALEC $1.54
- Average True Range (ATR)
- IAF 0.06
- ALEC 0.12
- MACD
- IAF -0.01
- ALEC -0.02
- Stochastic Oscillator
- IAF 49.44
- ALEC 28.36
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.